We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.59B
2
GE icon
GE Aerospace
GE
+$1.78B
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.38B
4
META icon
Meta Platforms (Facebook)
META
+$1.08B
5
PM icon
Philip Morris
PM
+$1.06B

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNOV icon
2901
MediciNova
MNOV
$65.5M
$31K ﹤0.01%
20,700
– –
DNMR
2902
DELISTED
Danimer Scientific, Inc.
DNMR
$31K ﹤0.01%
707
+191
+37% +$7.91K
DHX icon
2903
DHI Group
DHX
$166M
$30K ﹤0.01%
11,648
+466
+4% +$1.16K
MAGN
2904
Magnera Corp
MAGN
$443M
$30K ﹤0.01%
+1,139
New +$27K
BCOV
2905
DELISTED
Brightcove, Inc.
BCOV
$29K ﹤0.01%
+14,613
New +$32.1K
CCLD icon
2906
CareCloud
CCLD
$104M
$28K ﹤0.01%
23,700
– –
CTXR icon
2907
Citius Pharmaceuticals
CTXR
$21M
$28K ﹤0.01%
1,209
+84
+7% +$1.53K
OPTN
2908
DELISTED
OptiNose
OPTN
$28K ﹤0.01%
1,243
+76
+7% +$1.69K
NOTE
2909
DELISTED
FiscalNote
NOTE
$27K ﹤0.01%
1,633
+500
+44% +$8.46K
RXT icon
2910
Rackspace Technology
RXT
$1.18B
$27K ﹤0.01%
16,815
-24,400
-59% -$43.7K
MOND
2911
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$27K ﹤0.01%
11,275
+583
+5% +$1.34K
NDLS icon
2912
Noodles & Co
NDLS
$98M
$26K ﹤0.01%
1,637
-3,964
-71% -$77.4K
WHWK
2913
Whitehawk Therapeutics
WHWK
$269M
$26K ﹤0.01%
10,692
– –
WWR icon
2914
Westwater Resources
WWR
$81M
$23K ﹤0.01%
45,000
– –
ASRT
2915
DELISTED
Assertio
ASRT
$22K ﹤0.01%
1,469
+70
+5% +$955
LPTH icon
2916
Lightpath Technologies
LPTH
$862M
$22K ﹤0.01%
15,300
– –
PLX icon
2917
Protalix BioTherapeutics
PLX
$211M
$21K ﹤0.01%
15,982
– –
SKYX icon
2918
SKYX Platforms
SKYX
$163M
$21K ﹤0.01%
15,650
– –
BIRD icon
2919
Smartbird Inc
BIRD
$30.2M
$19K ﹤0.01%
1,299
+269
+26% +$5.02K
SCWO icon
2920
374Water
SCWO
$41.1M
$19K ﹤0.01%
1,495
+123
+9% +$1.58K
DRRX
2921
DELISTED
DURECT Corp
DRRX
$18K ﹤0.01%
14,210
– –
PROK icon
2922
ProKidney
PROK
$304M
$18K ﹤0.01%
10,485
– –
NGM
2923
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$18K ﹤0.01%
10,869
+783
+8% +$1.16K
BW icon
2924
Babcock & Wilcox
BW
$1.46B
$17K ﹤0.01%
14,589
+881
+6% +$1.09K
GWH icon
2925
ESS Tech
GWH
$18.8M
$16K ﹤0.01%
1,455
+112
+8% +$1.53K
115 116
117
118 119

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.